While this strategy increased targeting specificity, the potential for systemic on-target toxicity remained a significant concern due to PCNA’s widespread expression and the difficulty of achieving tumor-specific delivery for peptides (Zhao et al., 2011). Here, PCNA is linked to neoplasm.